AL-78898A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AL-78898A, covering 2013-06-04 to 2014-01-20. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD) [Phase 2]